Ionis Pharmaceuticals, Inc. (IONS) Stock Overview
Explore Ionis Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Ionis Pharmaceuticals, Inc. (IONS)
Key Financials
Key Financials
Market Cap
9.2B
P/E Ratio
-15.84
EPS (TTM)
$-1.72
ROE
-1.11%
IONS Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Ionis Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of IONS on the NASDAQ shows an RSI of 35.38, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $89.75 for the NASDAQ listing.
Key metrics behind Ionis Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of -15.84 and a market capitalization of 9.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of IONS on the NASDAQ.